Bridging Nations. Accelerating Therapies for Rare Diseases Together. The organization’s 2030 vision institutionalizes ...

ImmunityBio (NASDAQ: IBRX) recently announced a partnership with Accord Healthcare to expand European access to ANKTIVA for bladder cancer patients across 33 countries. ANKTIVA achieved a 71% complete ...

February 25, 2026 marks one year since KJ, an infant born with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, became the world's first person to receive a personalized CRISPR-based gene ...

Studying social behavior is crucial for understanding how certain neuromodulatory pathways—like the serotonin pathway, which influences mood and social interactions—are regulated. Kavita Babu, ...

SAN DIEGO - In what researchers describe as a historic step toward de-extinction science, an international team of gen ...

A new light-based sensor detects cancer markers at near-zero concentrations.

In the first State of the Union address of his second term, President Donald Trump played the health care hits, touting ...

Through an AI-enabled platform, the partnership between two non-profit groups seeks to bring overlooked cell and gene ...

On Feb. 20, NASA successfully conducted a countdown test for the Artemis II mission. It aims to send humans beyond low Earth ...

At an event on Monday, the agency officially unveiled long-awaited draft guidance meant to help speed the development of bespoke treatments for extremely rare diseases.

A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...

The 2026 Priestley Medalist and Nobel laureate struggled with finding her way through school before achieving the greatest feats in science ...